Online citations, reference lists, and bibliographies.

Nanoparticles Types, Classification, Characterization, Fabrication Methods And Drug Delivery Applications

Saurabh Bhatia
Published 2016 · Computer Science

Cite This
Download PDF
Analyze on Scholarcy
Share
The most emerging branch in pharmaceutical sciences known as “Pharmaceutical nanotechnology” presents new tools, opportunities and scope, which are expected to have significant applications in disease diagnostics and therapeutics. Recently nano-pharamceuticals reveal enormous potential in drug delivery as carrier for spatial and temporal delivery of bioactive and diagnostics. Additionally it also provides smart materials for tissue engineering. This discipline is now well-established for drug delivery, diagnostics, prognostic and treatment of diseases through its nanoengineered tools. Some nanotech based products and delivery systems are already in market. Pharmaceutical nanotechnology comprised of nano-sized products which can be transformed in numerous ways to improve their characteristics. Drugs that are transformed in to nano range offer some unique features which can lead to prolonged circulation, improved drug localization, enhanced drug efficacy etc. Various pharmaceutical nanotechnology based systems which can be termed as nanopharmaceuticals like polymeric nanoparticles, magnetic nanoparticles, liposomes, carbon nanotubes, quantum dots, dendrimers, metallic nanoparticles, polymeric nanoparticles, etc. have brought about revolutionary changes in drug delivery as well as the total medical service system. With the aid of nanopharmaceuticals, Pharmaceutical nanotechnology could have a profound influence on disease prevention to provide better insights into the molecular basis of disease. However some recently found health risk evidences limits their utilization in pharmaceutical industry. Some concerning issues like safety, bioethical issues, toxicity hazards, physiological and pharmaceutical challenges get to be resolved by the scientists. Current researchers are still lacking sufficient data and guidelines regarding safe use of these nanotechnology based devices and materials. Therefore pharmaceutical nanotechnology is still in infancy. The present chapter summarizes the types of nanopharmaceuticals with the most important applications and nanoparticles associated health risk related information available till present.
This paper references
10.1023/A:1015942306801
Protein Precoating of Polylactide Microspheres Containing a Lipophilic Immunopotentiator for Enhancement of Macrophage Phagocytosis and Activation
Y. Tabata (1989)
10.1016/J.IJPHARM.2007.08.002
Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99mTechnetium-fluconazole nanocapsules.
Danielle Nogueira de Assis (2008)
10.1158/1078-0432.CCR-05-2831
Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth
Zhuohan Zhang (2006)
10.1038/nrd2591
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
10.1016/0168-3659(90)90074-4
Intestinal transit of bioadhesive microspheres in an in situ loop in the rat—A comparative study with copolymers and blends based on poly(acrylic acid)
C. Lehr (1990)
10.4314/AJB.V7I25.59701
Protein nanoparticle: A unique system as drug delivery vehicles
M. Jahanshahi (2008)
10.1038/nrd2614
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1016/0168-3659(89)90005-9
The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process
F. Koosha (1989)
10.1016/S0168-3659(01)00235-8
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Y. Li (2001)
10.1097/01.rli.0000199292.88189.0f
Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications
A. Klibanov (2006)
10.1126/SCIENCE.1088755
Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins
J. Nam (2003)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
10.1016/S0927-7757(00)00825-6
Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method
Hye young Kwon (2001)
10.1155/2011/408675
Emerging technologies of polymeric nanoparticles in cancer drug delivery
E. Cobham Brewer (2011)
10.1007/s11596-008-0303-6
Antiviral activity of nano carbon fullerene lipidosome against influenza virus in vitro
H. Ji (2008)
10.3109/10731199809117682
Exploratory design in medical nanotechnology: a mechanical artificial red cell.
R. A. Freitas (1998)
10.2217/17435889.2.5.681
Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy.
X. Huang (2007)
10.1016/S0378-5173(01)00622-6
Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.
H. Boudad (2001)
10.3109/10611869808995872
Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography.
R. Löbenberg (1998)
10.15272/AJBPS.V2I14.123
Nanopharmaceuticals: A New Perspective of Drug Delivery System
Md. Zubayer Hossain Saad (2012)
10.1158/0008-5472.CAN-06-4762
Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system.
Bifeng Pan (2007)
R ECENT ADVANCES IN NOVEL DRUG DELIVERY SYSTEMS
Manivannan Rangasamy (2010)
10.1039/b806051g
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity.
Elodie Boisselier (2009)
10.1016/0168-3659(85)90056-2
Preparation of injectable controlled-release microcapsules by a solvent-evaporation process
T. R. Tice (1985)
10.1016/0021-9797(91)90044-9
Protein-surface interactions in the presence of polyethylene oxide. II, Effect of protein size
Seok Hee Jeon (1991)
Controlled drug delivery with nanoparticles : current possibilities and future trends
P. Couvreur (1995)
10.2174/157016210791330356
Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.
S. Mahajan (2010)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
V. Torchilin (1995)
10.1042/BST0350061
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
D. Tomalia (2007)
10.1016/J.JCONREL.2004.03.023
Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
N. Ubrich (2004)
10.1126/SCIENCE.297.5580.415
Hurdles and Hopes for Cancer Treatment
K. Hunt (2002)
10.1023/A:1016042504830
Atomic Force Microscopy Studies of Solid Lipid Nanoparticles
A. Mühlen (2004)
10.1007/BF02897257
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice
N. Chiannilkulchai (2008)
10.1039/c39900001423
Isolation, separation and characterisation of the fullerenes C60 and C70: the third form of carbon
R. Taylor (1990)
10.1166/JNN.2006.413
Pharmacytes: an ideal vehicle for targeted drug delivery.
R. Freitas (2006)
10.1615/CRITREVTHERDRUGCARRIERSYST.V23.I4.10
Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives.
M. Nahar (2006)
10.1111/j.2042-7158.1990.tb07033.x
Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency.
P. Jani (1990)
10.1016/J.CHEMBIOL.2005.08.014
Cationic fullerenes are effective and selective antimicrobial photosensitizers.
G. Tegos (2005)
10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
Design of folic acid-conjugated nanoparticles for drug targeting.
B. Stella (2000)
10.1016/S0168-3659(98)00138-2
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.
P. Scholes (1999)
10.1016/J.BBAGEN.2006.12.007
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
T. Dutta (2007)
10.1016/S0168-3659(96)01484-8
Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery
Cunxian Song (1997)
10.1002/jps.2600690222
Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles.
P. Couvreur (1980)
10.1016/0378-5173(89)90281-0
Nanocapsule formation by interfacial polymer deposition following solvent displacement
H. Fessi (1989)
10.1016/S0168-3659(99)00012-7
Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release.
M. Polakovič (1999)
10.1016/0378-5173(93)90015-8
A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure
B. Magenheim (1993)
10.1186/1477-3155-2-12
Nanoparticles – known and unknown health risks
P. Hoet (2004)
10.1016/J.FREERADBIOMED.2007.05.005
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism.
P. Mróz (2007)
10.1016/S0928-0987(97)86465-2
Chitosans of absorption enhancers of poorly absorbable drugs: Influence of molecular weight and degree of acetylation
N G Schipper (1996)
10.1039/b923560d
Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers.
Cristian Samorí (2010)
10.1016/J.ULTRAS.2007.11.002
Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy.
Z. Gao (2008)
10.1016/J.BIOMATERIALS.2003.08.069
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
M. Ravi Kumar (2004)
10.1002/anie.200902612
Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy.
Zhuang Liu (2009)
10.1016/0378-5173(83)90113-8
Physicochemical characterization of polyacrylic nanoparticles
J. Kreuter (1983)
10.3109/03639049809108571
Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.
D. Quintanar-Guerrero (1998)
10.4103/0250-474X.22957
Fullerenes: An introduction and overview of their biological properties
S. Thakral (2006)
10.1155/2012/751075
Noble Metal Nanoparticles Applications in Cancer
João Conde (2012)
10.1126/SCIENCE.1106185
Encapsulation of Molecular Hydrogen in Fullerene C60 by Organic Synthesis
K. Komatsu (2005)
10.1016/S0939-6411(97)00096-9
Lectins and bacterial invasion factors for controlling endo- and transcytosis of bioadhesive drug carrier systems
E. Haltner (1997)
10.2174/157016211798038588
Articulating A Rights-Based Approach to HIV Treatment and Prevention Interventions
D. Barr (2011)
10.1021/bc9002212
Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment.
Erik C Dreaden (2009)
Microbivores: Artificial Mechanical Phagocytes using Digest and Discharge Protocol
R. Freitas (2005)
10.1038/nrd725
Drug and gene targeting to the brain with molecular trojan horses
W. Pardridge (2002)
10.3109/10611869509015920
Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions.
E. Björk (1995)
10.1016/j.tibtech.2008.06.009
Bioinspired enzyme encapsulation for biocatalysis.
Lorena Betancor (2008)
10.1016/S0928-0987(99)00032-9
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
10.1016/S0163-7258(99)00073-X
Resistance mechanisms associated with altered intracellular distribution of anticancer agents.
A. Larsen (2000)
10.1016/j.biomaterials.2008.05.005
Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60).
Z. Marković (2008)
10.1016/j.jconrel.2008.08.019
Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound.
Y. Negishi (2008)
10.1038/nbt1006-1211
The emerging nanomedicine landscape
Volker Wagner (2006)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1016/J.ICS.2005.02.021
Development of a potential protein vector (NeuroTrans) to deliver drugs across the blood–brain barrier
R. Gabathuler (2005)
10.3390/s8053082
Near-Infrared Fluorescent Materials for Sensing of Biological Targets
Carrie L. Amiot (2008)
10.1038/NM0398-365
Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses
M. L. Hedley (1998)
10.1016/S0958-1669(00)00082-3
Applications of nanotechnology to biotechnology commentary.
J. West (2000)
10.1021/JA051977C
Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials.
J. Rolland (2005)
10.1039/b821763g
Gold nanostructures: a class of multifunctional materials for biomedical applications.
Claire M. Cobley (2011)
10.2165/00063030-200822010-00001
Convergence of Nanotechnology and Cardiovascular Medicine
N. Iverson (2012)
10.1016/J.IJPHARM.2004.07.029
Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos.
A. Vargas (2004)
10.1016/S0960-894X(00)00159-1
Antimycobacterial activity of ionic fullerene derivatives.
S. Bosi (2000)
10.1021/NL071456I
Alkali-metal-induced enhancement of hydrogen adsorption in C60 fullerene: an ab Initio study.
K. R. S. Chandrakumar (2008)
10.1016/S0169-409X(00)00116-2
Nanoparticulate systems for the delivery of antisense oligonucleotides.
G. Lambert (2001)
10.1016/S0378-5173(02)00058-3
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
J. Vandervoort (2002)
10.1023/A:1012153011884
Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat
N. Hussain (2004)
10.1080/026520400417658
Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization.
J. Molpeceres (2000)
10.1155/2007/76087
Clinical Potential of Quantum Dots
A. M. Iga (2007)
10.1023/A:1022676709565
Characterization of Crystalline Drug Nanoparticles Using Atomic Force Microscopy and Complementary Techniques
H. Shi (2004)
10.2967/jnumed.107.041723
Carbon Nanotubes: Potential Benefits and Risks of Nanotechnology in Nuclear Medicine
R. Reilly (2007)
10.1002/CHEM.200400422
Polymeric nanoparticles from rapid expansion of supercritical fluid solution.
Y. Sun (2005)
10.1159/000066249
Penetration of Titanium Dioxide Microparticles in a Sunscreen Formulation into the Horny Layer and the Follicular Orifice
J. Lademann (1999)
10.1096/fj.02-0088com
Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery
J. Panyam (2002)
10.1016/S0168-3659(97)00106-5
Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.
M. Zambaux (1998)
10.1023/A:1011485622697
The Synthesis and Testing of Anti-Cancer Therapeutic Nanodevices
J. Baker (2001)
10.1016/S0896-8446(01)00064-X
Particle design using supercritical fluids: Literature and patent survey
Jennifer Jung (2001)
10.1186/1752-0509-2-74
A review of imaging techniques for systems biology
Armen Kherlopian (2008)
10.1016/S0939-6411(00)00084-9
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
10.2217/17435889.1.1.5
Welcome to Nanomedicine
C. Martin (2006)
10.1002/JMRI.1880070629
Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages.
A. Moore (1997)
10.1073/pnas.0607705103
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
C. Lee (2006)
10.1038/354056a0
Helical microtubules of graphitic carbon
S. Iijima (1991)
10.1039/C3TB20100G
Synthesis and drug delivery of novel amphiphilic block copolymers containing hydrophobic dehydroabietic moiety.
J. Wang (2013)
10.1002/jnr.21805
Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
X. Cai (2008)
10.1016/0168-3659(93)90097-O
Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior.
T. Niwa (1993)
10.1111/j.2042-7158.1989.tb06377.x
The uptake and translocation of latex nanospheres and microspheres after oral administration to rats.
P. Jani (1989)
10.1186/1745-6673-2-16
Nanotechnology-based drug delivery systems
S. Suri (2007)
10.2174/1389201053167158
The impact of nanobiotechnology on the development of new drug delivery systems.
O. Kayser (2005)
10.1016/S0378-5173(02)00461-1
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.
M. H. El-Shabouri (2002)
10.1096/fj.04-2747rev
Nanomedicine: current status and future prospects
S. Moghimi (2005)
10.1016/J.JCONREL.2004.01.017
Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process.
J. Jaiswal (2004)
10.1201/9781498710565
Colloidal Drug Delivery Systems
J. Kreuter (1994)
10.1155/2011/202187
Gold nanoparticles: promising nanomaterials for the diagnosis of cancer and HIV/AIDS
Anil Kumar (2011)
10.1016/0168-3659(91)90140-9
Polymer-coated liposomes; stability and release of ASA from carboxymethyl chitin-coated liposomes
C. Dong (1991)
10.1016/J.SUPFLU.2005.08.003
Nanomaterials and supercritical fluids
E. Reverchon (2006)
10.1109/TNB.2005.850478
Carbon nanotubes for biomedical applications
N. Sinha (2005)
10.1016/J.IJPHARM.2004.12.021
Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice.
D. C. Bibby (2005)
10.1248/BPB.29.1790
Nanocarriers: promising vehicle for bioactive drugs.
M. Rawat (2006)
10.1016/J.ICS.2005.02.023
The use of Pep: Trans vectors for the delivery of drugs into the central nervous system
Jean‐Michel Scherrmann (2005)
10.1073/PNAS.95.18.10809
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
B. X. Chen (1998)
10.1016/0169-409X(95)00039-A
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
G. Storm (1995)
10.1016/0378-5173(95)00142-6
Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation
G. Puglisi (1995)
10.1016/J.IJPHARM.2007.10.034
Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology.
R. Suzuki (2008)
10.1007/BF02940287
Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles
C. Verdun (2008)
10.1038/347354a0
Solid C60: a new form of carbon
W. Kraetschmer (1990)
10.1016/S0169-409X(00)00120-4
Mucoadhesive nanoparticulate systems for peptide drug delivery.
H. Takeuchi (2001)
10.1038/aps.2011.82
Gold nanoparticles in cancer therapy
Zhao-Zhin Joanna Lim (2011)
10.1016/S0378-5173(01)00614-7
Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.
Q. Zhang (2001)
10.3109/02652049709006812
Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation.
M. Ueda (1997)
10.1016/J.LFS.2005.05.085
Pharmacokinetics and brain uptake of lactoferrin in rats.
B. Ji (2006)
10.1002/MRM.10406
MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles.
D. Artemov (2003)
10.1021/AR700089B
Functionalized carbon nanotubes in drug design and discovery.
M. Prato (2008)
10.1002/SMLL.200700351
Nanoplatforms for targeted molecular imaging in living subjects.
W. Cai (2007)
10.1002/cncr.22035
Emerging implications of nanotechnology on cancer diagnostics and therapeutics
A. Cuenca (2006)
10.1016/0168-3659(90)90103-Z
Indomethacin polymeric nanosuspensions prepared by microfujidization
R. Bodmeier (1990)
Drug-loaded nanoparticles : preparation methods and drug targeting issues
E. Alleman (1993)
10.1038/nbt994
In vivo cancer targeting and imaging with semiconductor quantum dots
X. Gao (2004)
10.2967/jnumed.106.039131
Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes
M. McDevitt (2007)
10.1148/RADIOL.2403051341
In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle.
P. Fatouros (2006)
10.1166/JNN.2003.077
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
J. Kreuter (2004)
10.1016/J.JCONREL.2003.11.012
Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
K. Jores (2004)
10.1021/mp300391v
In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry.
Lorenzo Albertazzi (2013)
10.1016/S0168-3659(00)00367-9
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
H. M. Redhead (2001)
10.1002/JBM.A.10057
Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications.
Hao Xu (2003)
10.1016/j.jconrel.2010.11.022
G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
Deborah S. Goldberg (2011)
10.1016/J.PHYSE.2004.07.013
Quantum dots in biology and medicine
R. E. Bailey (2004)
10.1016/J.JCONREL.2004.01.002
Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.
M. Oyewumi (2004)
10.1016/J.BIOMATERIALS.2005.04.041
Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.
C. Lemarchand (2006)



This paper is referenced by
10.1007/978-3-319-58538-3_53-1
Nano-wastes and the Environment: Potential Challenges and Opportunities of Nano-waste Management Paradigm for Greener Nanotechnologies
Sherif A. Younis (2018)
10.3389/fbioe.2019.00113
Use of Nanoparticles in Tissue Engineering and Regenerative Medicine
Milad Fathi-Achachelouei (2019)
10.1002/aoc.5609
Conjugation of pectin biopolymer with Au‐nanoparticles as a drug delivery system: Experimental and DFT studies
Bahareh Khodashenas (2020)
10.3390/cells9030679
Noble Metals and Soft Bio-Inspired Nanoparticles in Retinal Diseases Treatment: A Perspective
Valeria de Matteis (2020)
10.3390/jcm9030746
Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
B. Salehi (2020)
10.1016/j.actbio.2018.09.049
Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.
S. Uppal (2018)
10.14227/dt260319p28
In Vitro Performance Testing of Nanoparticulate Drug Products for Parenteral Administration
Elena Fecioru (2019)
Drug encapsulation in chitosan nanoparticles for dermal patch formulations
Aino Oisalo (2017)
10.1016/j.drudis.2019.03.004
Drug delivery to retinal photoreceptors
E. Himawan (2019)
Nano Based Drug Delivery Systems : Present and Future Prospects
(2019)
10.1080/10717544.2020.1754527
Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis
Salma A Fereig (2020)
10.1016/j.ejps.2017.05.036
Preparation and nanoformulation of new quinolone scaffold‐based anticancer agents: Enhancing solubility for better cellular delivery
Nehal H Elghazawy (2017)
DEVELOPMENT OF ONCE-DAILY MYCOPHENOLATE MOFETIL SUSTAINED RELEASE ORAL NANOPARTICLES
M. Mohammed (2017)
10.1016/j.ejpb.2019.09.020
The Lord of the Lungs: the essential role of pulmonary surfactant upon inhalation of nanoparticles.
Cristina García-Mouton (2019)
10.3390/ijms20040970
Jumping on the Bandwagon: A Review on the Versatile Applications of Gold Nanostructures in Prostate Cancer
Monira Sarkis (2019)
10.2217/nnm-2017-0208
Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
A. Grimaldi (2017)
10.3390/molecules25092193
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Abuzer Alp Yetisgin (2020)
10.1007/978-981-13-7607-8
Bioactive Natural Products for the Management of Cancer: from Bench to Bedside
Anil K. Sharma (2019)
10.1007/978-3-030-05569-1_21
Impact of Fabricated Nanoparticles on the Rhizospheric Microorganisms and Soil Environment
Mokula Mohammed Raffi (2019)
10.5772/intechopen.86818
Nanomaterials via Reconfiguration of Skeletal Matrix
R. Dongre (2019)
10.1590/1980-5373-MR-2018-0074
Process Evaluation of Sugar-Based Polymeric Colloidal Nanocarrier Formation
Thais Aragão Horoiwa (2019)
10.18799/24056537/2019/4/217
A review of nanotechnology applications in the oil and gas industries
B. M. Das (2019)
10.1016/j.xphs.2019.01.016
The Role of Surface Active Agents in Ophthalmic Drug Delivery: A Comprehensive Review.
Shaimaa S Ibrahim (2019)
10.1016/J.ARABJC.2018.11.007
Smart nanomaterials in pharmaceutical analysis
Deepali Sharma (2020)
10.1007/978-981-13-7607-8_9
Drug Resistance in Cancer and Role of Nanomedicine-Based Natural Products
Deeptashree Nandi (2019)
10.1002/9781119528463.CH14
Applications of Nanomaterials in Agriculture and Food Industry
Ashitha Jose (2018)
10.3390/biom9020056
Formulations of Curcumin Nanoparticles for Brain Diseases
M. L. Del Prado-Audelo (2019)
10.1016/j.ijbiomac.2018.07.030
Enzymes and nanoparticles: Modulation of enzymatic activity via nanoparticles.
Abdullah Arsalan (2018)
Fall 12-15-2017 SYNTHESIS AND CHARACTERIZATION OF ENZYME CATALYZED BIODEGRADABLE “ CLICK-ENE ” POLYMERS FOR TARGETED CANCER THERAPY
E. Alattas (2018)
10.33263/briac91.834841
Alternative strategies for fighting multidrug resistant bacterial infections
Paulina Podgoreanu (2019)
10.3390/cancers12040951
EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways
A. Farooqi (2020)
10.3390/bioengineering6010026
Nanostructured Materials for Food Applications: Spectroscopy, Microscopy and Physical Properties
S. Sharma (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar